DZ Alliance: Unlock Your Financial Potential

December 2, 2024

Why Is Purple Biotech Stock Trading Higher On Monday?

On Monday, Purple Biotech Ltd (NASDAQ:PPBT) reported the final results from the randomized Phase 2 study of its lead oncology drug, CM24, a humanized monoclonal antibody that blocks CEACAM1, in patients with pancreatic ductal adenocarcinoma (PDAC). Purple Biotech stock is trading higher with a strong session volume of 9.7 million, compared to an average volume of 48.73K as per data from Benzinga Pro. The Phase 2 study evaluated CM24 in combination with Bristol Myers Squibb & Co’s (NYSE:BMY) immu

December 2, 2024

Supermicro Stock Price Levels to Watch After Monday's Near-30% Surge

Supermicro shares jumped nearly 30% Monday after the server maker announced that an independent review of its accounting practices found no wrongdoing. Monitor these key chart levels.

December 2, 2024

Get ready for weaker returns in 2025 after huge stock gains in the last 2 years, Wharton professor Jeremy Siegel says

"Maybe for once, we will see relative softness on the big high flyers that have been so good for the market the last two years," Jeremy Siegel said.

December 2, 2024

Check out November's biggest stock market winners (and losers!)

Stocks generally enjoyed one of the best months of the year. Here's what else you should know about the markets into year-end.

December 2, 2024

Intel Stock Finishes Lower After Company Says CEO Has Retired

News that chip giant Intel will get a new CEO set the embattled chip maker's shares in motion Monday, with the stock finishing marginally lower as the company sought to reassure investors that things might improve after a punishing year.

December 2, 2024

Stocks could see an 'everything rally' if Trump tackles the US debt problem, market vet says

The US debt surpassed $36 trillion for the first time ever this year, according to Treasury Department data.

December 2, 2024

How To Earn $500 A Month From Marvell Technology Stock Ahead Of Q3 Earnings

Marvell Technology, Inc. (NASDAQ:MRVL) will release earnings results for the third quarter, after the closing bell, on Tuesday, Dec. 3. Analysts expect the Wilmington, Delaware-based company to report quarterly earnings at 41 cents per share. Marvell projects to report quarterly revenue of $1.46 billion. That’s more than the $1.42 billion it reported a year earlier, according to data from Benzinga Pro. On Nov. 27, Susquehanna analyst Christopher Rolland maintained Marvell Tech with a Positive ra